Abstract
Adaptations of animal cells to growth in suspension culture concern in particular viral vaccine production, where very specific aspects of virus-host cell interaction need to be taken into account to achieve high cell specific yields and overall process productivity. So far, the complexity of alterations on the metabolism, enzyme, and proteome level required for adaptation is only poorly understood. In this study, for the first time, we combined several complex analytical approaches with the aim to track cellular changes on different levels and to unravel interconnections and correlations. Therefore, a Madin-Darby canine kidney (MDCK) suspension cell line, adapted earlier to growth in suspension, was cultivated in a 1-L bioreactor. Cell concentrations and cell volumes, extracellular metabolite concentrations, and intracellular enzyme activities were determined. The experimental data set was used as the input for a segregated growth model that was already applied to describe the growth dynamics of the parental adherent cell line. In addition, the cellular proteome was analyzed by liquid chromatography coupled to tandem mass spectrometry using a label-free protein quantification method to unravel altered cellular processes for the suspension and the adherent cell line. Four regulatory mechanisms were identified as a response of the adaptation of adherent MDCK cells to growth in suspension. These regulatory mechanisms were linked to the proteins caveolin, cadherin-1, and pirin. Combining cell, metabolite, enzyme, and protein measurements with mathematical modeling generated a more holistic view on cellular processes involved in the adaptation of an adherent cell line to suspension growth.
Key points
• Less and more efficient glucose utilization for suspension cell growth
• Concerted alteration of metabolic enzyme activity and protein expression
• Protein candidates to interfere glycolytic activity in MDCK cells
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Adaptation of mammalian cell lines to growth in suspension in a chemically defined medium has significant advantages for the design and optimization of manufacturing processes for biologicals. It requires the cells to reorganize their physiology away from cell-cell and cell-surface interactions towards suspension growth. Proteomics is a powerful tool to track changes in the protein composition and expression that has already been used to investigate on the link between modified environmental conditions and physiological changes (Doolan et al. 2010; Kumar et al. 2008; Luz-Hernández et al. 2008; Meleady et al. 2011; Pascoe et al. 2007). In combination with biotechnological tools, which are widely used to study the influence of the medium on cellular metabolism and growth rate (Cruz et al. 1999; Genzel et al. 2005; Sussman et al. 1980), the behavior of cellular systems can be studied in more detail. However, so far, it is barely understood how concerted changes on the proteome, metabolome, and growth enzyme level compose a system response, which enables suspension growth. This is partly because of the highly complex mechanism of cell line adaptation and partly because of the immense number of samples to be analyzed and evaluated.
The adaptation of Chinese hamster ovary cells to suspension growth in chemically defined medium is a story of success that enabled high yields in the production of recombinant proteins (Bandaranayake and Almo 2014; Kildegaard et al. 2013). But there is no suspension cell line available, which allows for the establishment of a similar platform approach for viral vaccine production. In particular, only few suspension cell lines qualify for manufacturing. Due to strict host cell specificity of many viruses, even adherent cultivation conditions are still a pivotal element in vaccine production. Madin-Darby canine kidney (MDCK) cells efficiently propagate various influenza virus strains (Genzel and Reichl 2009; Gregersen et al. 2011). For this cell line, different successful adaptations to suspension growth have been reported. So far, the human siat7e gene expressing MDCK cells (Chu et al. 2009) as well as suspension cells derived from adherent MDCK cells of the American and European collection of cell cultures (Huang et al. 2015; Lohr et al. 2010; van Wielink et al. 2011) are available for research purpose and some are even used for manufacturing of influenza vaccines (Donis et al. 2014; Doroshenko and Halperin 2009; Genzel and Reichl 2009; Gregersen et al. 2011; Manini et al. 2015; Onions et al. 2010; Perdue et al. 2011).
Adherent MDCK cell lines (MDCKADH) have been extensively studied regarding growth characteristics (Bock et al. 2009; Genzel et al. 2006; Mohler et al. 2008), extracellular and intracellular metabolite dynamics (Rehberg et al. 2014a; Rehberg et al. 2014b) including enzyme activity measurements (Janke et al. 2010b). The MDCK.SUS2 cell line (MDCKSUS2) was adapted earlier to growth in suspension by our group (Lohr et al. 2010). Until recently, analyses were mainly limited to a descriptive level and few factors affecting changes were observed (Kluge et al. 2015; Lohr et al. 2010). For the first time, we now combine analyses of growth behavior, enzyme activity measurements, and proteomics with model-based approaches to study the adaptation of cell lines to new growth conditions. In the first part of our study, cell growth of the MDCKSUS2 cell line was analyzed using a segregated model for cell growth (Rehberg et al. 2013a) providing specific growth rates, uptake rates, and yield coefficients. Afterwards, potential metabolic flux rates are compared to measurements of key enzyme activities and cross-checked with relative abundance from the proteome analysis to resolve shifts in central carbon metabolism. Finally, proteomic data were used to further analyze biosynthesis as well as cellular signaling to identify hints for metabolic alterations caused by cell line adaptation to growth in suspension in a chemically defined medium. All these parts are then brought together to track changes on different cellular levels and to identify interconnections and correlations.
Materials and methods
Modeling suspension growth
The model of Rehberg et al. (2013a) for adherently growing MDCK cells was adapted to describe growth in suspension. As cells originate from an exponentially growing pre-culture, the initial distribution of cells spreads over various diameter classes X1, …, X5 such that the increase in the total cell number (Xtot) already satisfies \( {\dot{X}}_{\mathrm{tot}}={\mu}_{\mathrm{max}}{X}_{\mathrm{tot}} \) at initial times of cultivation (see Online Resource 1) with μmax as the maximum specific cell growth rate. In other words, we exclude the lag phase that is typically found after inoculation. Furthermore, water evaporation was excluded (kevap = 0) and parameters related to Xtot or the volume of all cells (VC) are scaled to the medium volume. In particular, this applies to units of the cell growth specific yield coefficient of glucose (YX/Glc) and glutamine (YX/Gln), the medium volume–specific glucose uptake rate for maintenance (mGlc), the medium volume–specific glutamine uptake rate for maintenance (mGln), and the approximate cell volume for larger times (\( {V}_{\ast}^C \)). Since the citric acid cycle can be supplied from glutamate (Glu), the uptake of Glu was implemented as first-order rate law with the following:
where kGLT is the cell number-specific activity of the glutamate transporter, \( {V}_S^C \) is the cell specific volume, and f is a growth inhibition factor. Accordingly, the glutamate transport is activated with an increase in f as already described (Rehberg et al. 2013b). A more detailed description of the model is given in Rehberg et al. (2013a), the source code of the model is provided in the Supplementary Material and parameters are listed in the Online Resource 1.
For model fitting, estimation of the parameter confidence intervals, and visualization of the results MATLAB© (Version R2007b, The MathWorks, Inc.) was used (Rehberg et al. 2013a). Determination of parameters was performed simultaneously on individual batches and ranges are reported where appropriate. Models and data were handled with the Systems Biology Toolbox 2 developed by Schmidt and Jirstand; integration of the ordinary differential equations was performed with the CVODE from SUNDIALS by Cohen and Hindmarsh. The algorithm Scatter Search For Matlab (SSm, (Egea et al. 2007)) was used for stochastic global optimization of parameters and initial conditions. All simulations were carried out on a Linux-based system.
Experimental methods
Media, solvents, and buffers labeled aqueous (aq) were prepared with filtered water from a water purification system (Milli-Q Advantage A10, Millipore, Schwalbach, Germany). For mass spectrometric analysis, an additional filter unit to the water purification system was added to remove trace organics (LCPAK0001). Chemicals for cell cultivation had synthesis grade, and chemicals for mass spectrometry (MS) had MS grade. Experiments were performed at 21 °C room temperature if not explicitly stated.
Cell line and cultivation conditions
From the MDCKADH, obtained from ECACC (No. 84121903), the suspension cell line MDCKSUS2 was derived following the protocol described by Lohr et al. (Lohr et al. 2010). For cultivation of MDCKADH, GMEM (Gibco Invitrogen, Germany, No. 22100-093) and for cultivation of MDCKSUS2, SMIF08 medium (protein- and peptide-free, chemically defined medium available from Gibco Invitrogen (Germany) by contact through K. Scharfenberg, Fachhochschule Emden/Leer, Germany) was used as described previously (Peschel et al. 2013). Cell concentrations and viability were determined with a ViCell XR (Beckman Coulter, Germany) after trypan blue staining (filtered 0.4% w/v trypan blue with 150 mM NaCl (aq), Carl-Roth, Germany). In case of microcarrier cultivations, a hemacytometer was used to determine cell concentrations (Bock et al. 2009). Cell viability was always around 90% during passaging.
Stirred tank bioreactors were inoculated with either pre-cultures of MDCKADH cells cultivated in roller bottles (Cellmaster 850 cm2 from Greiner Germany, caps tightly closed, 250 mL medium, 4 days growth, 0.66 rpm,), or with pre-cultures of MDCKSUS2 cells cultivated in shaker flasks (baffled Erlenmeyer flask from Corning Incorporated Germany, vent 0.2 μm cap, 100 mL medium, 3 days growth, 185 rpm) at 37 °C. The actual cultivations were carried out in the cellferm-pro® system (DasGip AG, Germany), or in the BIOSTAT® B plus system (Sartorius stedim biotech, Germany) with a starting cell concentration of 0.3 × 106 cells/mL in 1 L medium. For cultivation of MDCKADH cells, microcarrier (Cytodex 1, GE, Sweden) were added in a concentration of 2 g/L equal to about 8000 carriers/mL. The bioreactor was equipped with a pitched-blade stirrer operated at 50 rpm in case of MDCKADH and 75 rpm in case of MDCKSUS2. Temperature was controlled at 37 °C. Oxygen partial pressure was set to 40% by pulsed aeration with air enriched with 7.5% CO2 and 20% O2. The pH value of the media was controlled at 7.3.
Cellular cultivations were independently repeated five times for MDCKSUS2 and three times for MDCKADH cells. The first two batches with MDCKSUS2 cells in the BIOSTAT® B plus system were used for enzyme activity measurements and a strict sampling scheme was performed to determine cell concentration, pH value, and metabolite concentrations of glucose (Glc), Glu, glutamine (Gln), lactate, and ammonia. Metabolites were measured as described (Genzel et al. 2004). For follow-up cultivations, MDCKSUS2 and MDCKAHD cells were adapted to growth in media with lower concentrations of Glu (1.5 mmol/L) and Gln (4 mmol/L) over three consecutive batches each. These batches were performed using both cell lines alternating in the cellferm-pro® system with minimal sampling for proteomic comparison.
Enzyme activity assays
Enzyme activities were quantified with three technical replicates each as described by Janke et al. (Janke et al. 2010a; Janke et al. 2010b). In short, cells were harvested at a cell concentration of 1.3 × 106 cells/mL. After washing with ice-cold phosphate-buffered saline (200 g, 5 min, 0 °C), samples were frozen in liquid nitrogen and stored at − 80 °C. For direct and indirect enzyme activity assays, samples were kept on ice. Enzyme extraction was performed by sonication (maximum power, 30 s, Sonopuls HD2200, Bandelin, Germany) in a 1-mL extraction buffer (Janke et al. 2010b). Afterwards, the extract was centrifuged at 16,000 g for 5 min to remove cell debris. The supernatant was used to measure the respective enzyme activities as previously described.
Sample preparation for proteomic analysis
Preparation of all samples was carried out on ice. At 70 h of cultivation and a cell concentration of 1 × 106 cells/mL (± 0.1 ×106 cells/mL, n = 3), cells in a 100-mL medium were harvested by either carrier sedimentation (MDCKADH cells) or by centrifugation at 300 g, 5 min and 4 °C (swing-out rotor, type 7591, Heraeus, Germany; MDCKSUS2 cells). Cells in the supernatant of microcarrier cultures were also harvested, treated like MDCKSUS2 cells, and finally pooled with the carrier fraction. All samples were washed three times with Tris-buffer 30 mM (aq) Tris (Sigma-Aldrich, Germany), 150 mM (aq) NaCl (Merck KGaA, Germany), 1 mM (aq) phenylmethylsulfonylfluoride (Sigma-Aldrich, Germany), pH 7.6). Afterwards, cells were lysed at a ratio of 2:1 (v/v, sample to buffer) with sodium dodecyl sulfate–based lysis buffer (Tris-buffer, 0.5% (w/v, aq) sodium dodecyl sulfate (AppliChem GmbH, Germany), 1 mM (aq) magnesium chloride hexahydrate (AppliChem GmbH, Germany), 5 mM (aq) ethylenediaminetetraacetic acid disodium salt dihydrate (Sigma-Aldrich, Germany), and protease inhibitor (Complete Ultra Tablets, Mini Easypack, Roche Applied Science, Germany), 50 mM dithiothreitol. Lysate was homogenized by pipetting through a syringe (0.7 × 16 mm, Sterican Heparin, Tuberkulin, B. Braun Medical AG, Germany) and frozen at − 80 °C.
Samples were thawed at room temperature and treated for 30 min with benzonase (benzonase, 25 U/μl, nuclease, purity > 99%, CN: 70664-3, Millipore, UK) at a ratio of 1:2000 (v/v, sample to enzyme). All samples were filtered (pore size: 100 μm, Partec GmbH, Germany) to remove carriers from the MDCKADH cell samples. An ultracentrifugation step (360.000×g, 30 min, 20 °C) was performed to remove insoluble particles. Protein concentrations were measured with a BCA assay kit (Pierce, Thermo Scientific, Germany).
Proteome analysis
For proteome analysis, sample preparation was performed using a spin filter (Nanosep 10K omega, Pall Life Sciences, USA) to remove persistent interfering substances from the media (i.e., pluronic, (Manza et al. 2005). Therefore, the protein solution was applied to a filter unit (10 kDa, Pall, Germany), and centrifuged at 13.000 g for 10 min. After two washing steps with a 200-μL urea solution (8 M urea in 0.1 M (aq) Tris/HCl (AppliChem, Germany), pH 8.5), 100 μL of 50 mmol/L iodoacetamide solution (in urea solution, Sigma-Aldrich, Germany) was added. The filter unit was shaken for 1 min at 600 rpm (Thermomixer Comfort, Eppendorf, Germany), and incubated for 20 min in the dark. After centrifugation, three washing steps with a 100-μL urea solution and three washing steps with 100 μL 50 mM (aq) ammonium bicarbonate buffer (Fluka Analytical, Germany) were performed. Trypsin solution was added to the filter unit in a volume of 50 μL (50:1 (w/w, sample: trypsin), in ammonium bicarbonate buffer, with 5% (v/v) acetonitrile (ACN, Fluka Analytical, Germany) and 1 mM CaCl2 (AppliChem, Germany)). After shaking for 1 min at 600 rpm, the digestion was incubated for 7 h at 37 °C. The filter unit was placed onto another reaction tube. The filtrate was gained after centrifugation, and the filter unit was washed with a 50-μL digestion buffer (without trypsin) and 70 μL of water.
The filtrate was vacuum-dried (SPD 121P centrifuge, coupled to refrigerated Vapor Trap, Thermo Scientific, Germany) and re-suspended in 50 μL trifluoroacetic acid (TFA) solution for liquid chromatography (LC) separation (0.1% (v/v) TFA (Fluka Analytical, Germany), 2% (v/v) ACN). Digestion quality was tested with a 1-μL sample using monolithic high-performance LC (HPLC) separation (Ultimate 3000 nano LC system, Thermo Scientific, Germany) and UV detection at 214 nm as described (Burkhart et al. 2012). Sample solution was aliquoted in 2-μL volumes and vacuum-dried.
Dried samples were re-suspended in 0.1% (aq) TFA and equal peptide content was verified by the absorbance of the peptide bond at 205 nm with a NanoDrop2000 (Thermo Scientific, Germany). For nano LC−MS/MS analysis, a Q-Exactive mass spectrometer (Thermo Scientific, Germany) was online coupled to a nano RSLC HPLC system (Thermo Scientific, Germany). A total of 1.5-μg peptides (referred to the starting material of 50 μg) in 15 μl 0.1% (aq) TFA was injected. Samples were loaded onto a trap column (C18, 100 μm × 2 cm PepMap RSLC, Thermo Scientific, Germany) at a flow rate of 20 μL/min with 0.1% (v/v) TFA solvent. Subsequently, peptides were separated on a 50-cm main column (C18, 75 μm × 50 cm PepMap RSLC, Thermo Scientific) using a binary gradient consisting of mobile phase A (0.1% (v/v, aq) formic acid) and mobile phase B (0.1% formic acid, 84% ACN) at a flow rate of 250 nL/min and 60 °C. Gradients increased linearly from 3 to 42% B in 90 min. The Q-Exactive was operated in data-dependent acquisition mode acquiring full MS Scan in a mass range of 300–1500 m/z (R = 70,000) followed by MS/MS of the 15 most abundant ions (R = 17,500). Charge states +2 to +5 were selected for high energy collision dissociation fragmentation with a dynamic exclusion of 12 s and a collision energy of 27%. Target values and fill times were set to 3 × 106 and 120 ms for MS and 5 × 104 and 250 ms for MS/MS.
Proteome data evaluation
Label-free quantification was performed using the software Progenesis LC-MS 3.0 (Nonlinear Dynamics, Germany). LC-MS runs were aligned to an automatically selected reference run. After peak picking, a list of the features was exported and analyzed using SearchGUI (Vaudel et al. 2011). Therefore, the list was divided 15 times and analyzed using the OMSSA and X!tandem search algorithm through the Uniprot/Trembel database (2013/07) of Canis familiaris entries. The peak list from raw spectra, the list from the search engine MASCOT and the used database were uploaded at MassIVE (ftp://massive.ucsd.edu/MSV000086277/). Established search parameters: tryptic digest with a maximum of one missed cleavage; fixed modification—carbamidomethylation of cysteine, variable modification—oxidation of methionine; peptide charge 2+ to 4+; monoisotopic peptide masses; peptide tolerance of 0.3 Da; MS/MS tolerance of 0.5 Da. Data were imported into Peptide-Shaker (Version 0.22.5) and corrected with a false discovery rate of 0.05 (Barsnes et al. 2011; Vaudel et al. 2011). Afterwards, result files were imported to Progenesis and protein lists with calculated protein quantities were exported to Excel. For statistical analysis of the data, a Student’s t-test with a p-value < 0.05 was performed with R (R Core Team 2008).
For the evaluation of the proteome of MDCKADH and MDCKSUS2 cells, only proteins with at least 1.4-fold induction (summed up peptide peak intensities) of at least three unique peptides (software Progenesis LC-MS) were considered. Proteins were grouped according to the biological processes of the human homolog protein (translated by Uniprot BLAST (Consortium 2014) and bioDBnet (Mudunuri et al. 2009)) described in Uniprot (Consortium 2014).
Results
Cell growth
For the analysis of experimental results of MDCKSUS2 cell growth in stirred tank bioreactors, a model for MDCKADH cells described by Rehberg et al. (2013a) was adapted to characterize suspension growth. The model used cell growth-specific parameters (Table 1) and experiment-specific parameters (Online Resource 1). It provided growth rates, metabolic uptake rates, as well as yield coefficients and allowed an insight into the dynamics of MDCKSUS2 cell cultivation and a comparison with MDCKADH cell growth (Table 1). In general, the segregated model was in good agreement with the measured data points for cell number, Glc, Gln, and Glu concentrations (Fig. 1).
Cell concentration increased over the time from about 0.3 × 106 cells/mL to a maximum of 4 × 106 cells/mL (Fig. 1a). Maximum cell specific growth rates of 0.013–0.014 h−1 were observed and represent a reduction to 25–30% compared to MDCKADH (Table 1). Minor differences between the cultivations in initial cell concentrations increased over the time course of cultivations (Fig. 1a). Samples for enzyme activity measurements were taken at a concentration of 1.3 × 106 cells/mL at 40 h and 58 h. The proteomic samples were taken between 60 and 70 h at a cell concentration of about 1 × 106 cells/mL.
As the cell diameter stayed nearly constant during cultivations (Fig. 1b), the shape of the curves of cell number and cell volume were similar (Fig. 1a and 1c). Only towards the end of cultivations, the cell diameter slightly decreased, which is also described by the model. Initial changes in the cell diameter were small and probably attributed to the transfer of cells from one cultivation vessel to another, which resulted in a minor difference between data and model prediction (Fig. 1b).
Following the time course of cell volume, a transition from exponential growth to a growth inhibition phase is likely due the plateau forming at the end of cultivations (Fig. 1c). This growth inhibition might be related to the rather high cell densities or substrate limitations. A clear separation of growth phases usually seen for MDCKADH cells (Rehberg et al. 2013a) was not observed in these data.
Metabolite pools and uptake rates
Over the time course of cultivations, MDCKSUS2 cells took up about half of the Glc (Fig. 1d). The decrease was relatively constant and ceasing towards the end of the cultivations. Regarding the Glc uptake rate, a distinct change was visible after three and four days (Fig. 1g). The calculated Glc uptake rate of 40 mmol/L/h decreased to 10 mmol/L/h. Compared to MDCKADH cell growth (Rehberg et al. 2013a), the Glc update rate and, at the same time, the cell specific yield coefficient for Glc was reduced to 20%, which implies less and more efficient glucose utilization for cell growth (Table 1). Accordingly, the specific yield of lactate from glucose was lower compared to MDCKADH with only 0.86–0.99 (Table 1), which represents a reduction to 40%. Average specific air flows of 0.11 day-1 and 0.20 day−1 were determined for MDCKSUS2 and MDCKADH cells, respectively (see Online Resource 2). This corresponds to a ratio of 0.36 and 0.24 for the maximum specific air flow rate to the maximum specific growth rate (MDCKSUS2 0.11/0.31 day−1/day−1; MDCKADH 0.20/0.86 day−1/day−1). Accordingly, with all the caveats of air flow measurements, MDCKSUS2 cells seem to have a higher oxygen demand (50 %) during the exponential growth phase. MDCK cells convert the substrate Glc to lactate by aerobic glycolysis for the generation of cellular energy. A decreased activity of aerobic glycolysis for MDCKSUS2 cells, indicated by the generally lower Glc uptake rate and lower glucose specific yield of lactate compared to MDCKADH, may indicate a higher energy supply by the citric acid cycle.
The substrate Gln decreased over the cultivation time, reflecting the demand by the cells, which is high during cell growth and low during cell maintenance phase (Fig. 1e). The decrease was constant with an anticipated flattening at the end of cultivations. Regarding the Gln uptake rate, a distinct change was visible after 3 and 4 days (Fig. 1h), similar to the Glc profiles. The Gln uptake rate of 15 mmol/L/h decreased to 1 mmol/L/h, which is slightly higher than for MDCKADH (12 mmol/L/h) with a somewhat higher cell specific yield coefficient for Gln (Table 1). Sources for citric acid cycle intermediates are intracellular Gln and Glu, while their conversion by glutaminolysis to α-ketoglutarate yields intracellular ammonium, which can be used for O-linked N-acetylglucosaminylation (Ryll et al. 1994) or can be directly transferred to other amino acids. The remains of ammonium was released as ammonia by the cells and yielded an increase in extracellular concentrations, which was similar for both cell lines (data not shown).
Glc and Gln uptake rates dropped after 3 and 4 days together with a decrease in Glu concentration (Fig. 1f). For MDCKADH cells, it was shown that the Glu transport was activated when the cells were growth inhibited (Rehberg et al. 2013a). The same correlation can be assumed for MDCKSUS2 cells as the Glu uptake rate showed a peak like behavior before the cell volume transitions from exponential growth to a growth inhibition phase (Fig. 1c and 1i). This phase was named as intermediate phase by Rehberg et al. (2013a), where the cells switch into maintenance metabolism. The maintenance substrate uptake rates were defined as the basal consumption that is required to sustain the actual biomass and were also simulated with the model (data not shown). The maintenance rate of MDCKSUS2 cells for Glc dropped to 20% compared to MDCKADH cells (Table 1). The maintenance rate for Gln was negligible, which indicates that glutamine was not required for cellular maintenance as also observed for MDCKADH cells (Table 1).
Differences between the three simulated cell cultivations are noticeable, especially for the mean of the three independent experiments performed for proteomic analysis (Fig. 1, red line). For the latter, concentrations of Glu and Gln were adapted to the cellular demand and halved in concentration compared to the two independent cultivations performed for enzyme activity measurements with a strict and comprehensive sampling scheme. To explain the drop of Glc and Gln uptake rates as well as the activation of Glu uptake (Fig. 1f), the mathematical model had to predict different timings of growth inhibition for the cultivations. However, the segregated model was in good agreement with all measured data points in a simultaneous use of identical growth parameters (Table 1), which highlights robust growth dynamics and a similar metabolic regimen.
Altered maximum enzyme activities for MDCKSUS2 cells
The maximum catalytic activities of 27 enzymes from central carbon metabolism for MDCKSUS2 cells were measured during substrate saturation using an assay platform developed by Janke et al. ((Janke et al. 2010b), Table 2). The enzyme activities were measured in relation to the applied protein amount of cell extracts. At the sampling point with a cell concentration of 1.3 ×106 cells/mL, the determined protein amount per 106 cells was 0.22 ± 0.04 mg protein for MDCKSUS2 cells and 0.18 ± 0.01 mg protein for MDCKADH cells.
Activities of the different enzymes covered four orders of magnitude (0.2 nmol/min/mg protein (pyruvate dehydrogenase) to 2548 nmol/min/mg protein (malate dehydrogenase)) for MDCKSUS2 cells. High activities (> 1000 nmol/min/mg protein) were found for malate dehydrogenase, pyruvate kinase, lactate dehydrogenase, and triose-phosphate isomerase, while the other enzyme activities were in the range of 1–400 nmol/min/mg protein. The lowest enzyme activities were found for pyruvate dehydrogenase (PDH), pyruvate carboxylase and NADH-linked isocitrate dehydrogenase (< 1.5 nmol/min/106 cells), indicating possible rate-limiting steps in the metabolic pathway.
For a comparison of the MDCKSUS2 cell line with its parental MDCKADH cell line, the maximum enzyme activities measured by Janke et al. were listed in Table 2 (Janke et al. 2011), and the ratio MDCKSUS2:MDCKADH was calculated. A decreased maximum enzyme activity for MDCKSUS2 cells (ratio < 0.7) was determined for 22 enzymes, which included all analyzed enzymes for glycolysis and anaplerotic reactions, most analyzed enzymes of the pentose phosphate pathway, citric acid cycle, and glutaminolysis (two enzyme activities were equal). For three enzymes, glutamate dehydrogenase, acetate-CoA ligase, and NADP-linked isocitrate dehydrogenase increased maximum enzyme activities were found for MDCKSUS2 cells compared to MDCKADH cells (ratio > 1).
Protein expression changes of metabolic enzymes
Comparative proteomic analysis between MDCKSUS2 and MDCKADH cells was focused to the metabolic enzymes analyzed before. Overall, 23 of the 27 enzymes were detected by the proteomic approach. Interestingly, for 65% of the enzymes, we observed significant changes in intracellular protein levels (Table 2, 15 enzymes, p-value < 0.05). For example, the intracellular protein level of two enzymes (glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase) of the pentose phosphate pathway was reduced in MDCKSUS2 cells compared to MDCKADH cells (Table 2), which might explain the differences in maximum enzyme activity. Also, differences in intracellular protein levels for acetate_CoA ligase (increase), citrate lyase (decrease), and glutaminase (decrease) correlated with the corresponding enzyme activity ratios (Table 2). On the other hand, for transketolase, a slightly higher intracellular level of protein was found (1.26) despite a similar enzyme activity ratio (0.99).
In contrast, changes in enzyme activities of anaplerotic reactions and of citric acid cycle seemed not to be related to intracellular protein levels (Table 2). In these pathways, only malic enzyme and NADP-linked isocitrate dehydrogenase show a concerted alteration of protein quantity and enzyme activity.
Differences in intracellular protein expression levels
Beyond MS-based analysis of expression levels of enzymes, a total of 976 proteins was examined for differences in MDCKSUS2 and MDCKADH cell cultivations. Analysis of protein data (Student’s t-test with a p-value < 0.05, at least 1.4-fold expression) resulted in 287 differentially expressed proteins (Online Resource 3). Most of the proteins could be assigned to the following functional classes: metabolism, gene expression, signaling pathway, and membrane associated protein (Fig. 2). Thus, a comprehensive change in protein expression of MDCKSUS2 cells occurred after cell line adaptation with obvious alterations in adhesive cell membrane components and intracellular signaling pathways. To focus the analysis, these 287 proteins were evaluated by Uniprot database search and literature research to identify interconnections to the observed alterations in enzyme activity levels of MDCKSUS2 and MDCKADH cells. Of those, pirin, cadherin-1, caveolin (CAV1), and AMP-activated protein kinase (AMPK) were described to have a direct impact on cellular metabolism (Table 3).
The list of significantly differentially expressed protein candidates (Online Resource 3) highlighted also various proteins of the respiratory chain (eight proteins) to be increased on average 1.6-fold for MDCKSUS2 cells compared to MDCKADH cells (Table 4). These findings might be related to the expression of CAV1, which is involved in mitochondrial membrane structure as described by Nwosu et al. (2016). Additionally, levels of four Ras-related proteins were decreased for MDCKSUS2 cells (Table 4). MDCK cells are widely used for studies of epithelial-mesenchymal transition. In general, MDCK cells show an epithelial phenotype, while oncogenic Ras-transformed MDCK cells undergo a transition and show a mesenchymal phenotype (Shukla et al. 2015). However, the decreased expression of Ras-related proteins for MDCKSUS2 cells did not seem to be correlated with the Ras-induced transition pathway.
Discussion
The complex process of MDCK cell adaptation to growth in suspension in a chemically defined medium was firstly analyzed regarding basic aspects such as general growth properties and metabolism (Lohr et al. 2010). In a proteomic study, differences between the parental and MDCKSUS2 cells during stepwise adaptation and the potential function of various proteins involved were investigated (Kluge et al. 2015). In this work, as a new approach, model-based growth characterization, enzyme activity analysis, and in-depths proteomics were combined with the aim to evaluate interconnections and correlations of cellular adaptation processes more holistically and to uncover more general rules of this complex process. A variety of hypotheses are discussed in the following.
The applied cell growth model describes the data of the MDCKSUS2 growth in a stirred tank bioreactor well and allows a detailed comparison of suspension and adherent growth for MDCK cells and their basic metabolism. In general, the specific cell growth rates for MDCKSUS were reduced to 30% compared to MDCKADH, which had an influence on the uptake and use of substrates. However, the general metabolic concept of using Glc and Gln during cell growth and shifting to Glu consumption during growth inhibition (Rehberg et al. 2013a) was very consistent with MDCKADH cells. At the end of cultivations, the cells transitioned to cellular maintenance metabolism that differed in glucose use between both cell lines.
A clear separation of growth phases for MDCKSUS2 cells based on cell concentration or cell volume as described for the adherent cell line was difficult (Rehberg et al. 2013a). As expected, an extended lag phase after inoculation, which is due to attachment of microcarriers before initiation of cell division steps, was missing for MDCKSUS2 cells compared to MDCKADH cells. It seems that dynamics of MDCKSUS2 cell growth is more susceptible to differences in inoculation conditions. At the end of cultivations, MDCKADH are usually fully growth inhibited by the limitation in microcarrier surface, while the inhibition of MDCKSUS2 cell growth seems to be a related to various factors, i.e., reduced nutrient levels and high cell densities. Apart from growth inhibition, both cell lines are similar in their overall growth behavior. Since nutrient use differed significantly between the cell lines, a shift in intracellular metabolism and a re-routing of cellular building blocks was apparent.
In case of glucose, the volume-specific Glc uptake of MDCKSUS2 cells, at the beginning of cultivations, started only at 40 mmol/L/h (Fig. 1) compared to the 200 mmol/L/h of MDCKADH (Rehberg et al. 2013a). This corresponds to a reduction to 20% in glycolytic activity and correlates with a reduction in cell growth (25–30%) and in measured maximum enzyme activities to 4–40%. Apparently, adaptation of MDCK cells to growth in suspension resulted in a consistent reduction in growth, glucose uptake, and glycolytic enzyme activities. The cell growth specific yield coefficient for glucose also dropped to 20% and the yield coefficient for lactate was reduced to 40%, which means that glucose was used more efficiently for cell growth. The cell volume–specific Gln uptake slightly increased in MDCKSUS2 cells to 115%, while maximum enzyme activities that contribute to the citric acid cycle were reduced to 12–85%. Therefore, a correlation between enzyme activities and uptake of Gln was not seen for the citric acid cycle. However, a correlation between uptake of Gln and enzyme protein levels existed. Since the cell growth specific yield coefficient for Gln remained high in MDCKSUS one hypothesis is that Gln use in the citric acid cycle was still high, as explained in the following section. Another hypothesis is that Gln was not fully used in the citric acid cycle, but for other anaplerotic reactions. Therefore, changes in nutrient uptake could be compensated by changes of the corresponding enzyme activities if these nutrients were not required in larger amounts by other pathways.
All measurements for monitoring the maximum enzyme activity were related to the protein amount per cell. Therefore, an increase in maximum enzyme activity may indicate a higher expression of the enzyme relative to other cellular proteins. This implies that a shift in enzyme activity required an increase in expression level of single proteins. Under these assumptions, proteomic analysis correlated with maximum enzyme activity and could explain about 65% of altered enzyme activities of MDCKSUS2 cells compared to MDCKADH cells (15 measured enzymes of 23 detected enzymes by proteomics). Interestingly, protein expression of enzymes of the citric acid cycle was upregulated for MDCKSUS2 cells, which fits to the high Gln uptake discussed earlier, but translates not into maximum enzyme activities as a decrease was observed. Higher protein levels but lower maximum enzyme activities may speak for differences in the level of co-factors or differences in protein modifications, which can both modulate the specific enzyme activity. A similar picture is seen for PDH and pyruvate carboxylase and may, again, point towards a control of metabolism at the level of enzyme activity rather than enzyme concentration.
The evaluation of proteomic data uncovered four regulatory mechanisms that could contribute to metabolic adaptations of the MDCKSUS2 cell line (summarized in Fig. 3). First, a 4-fold increase in pirin expression was observed for the suspension cell line. A pirin ortholog was examined in the bacterium Serratia marcescens, which bound to the PDH subunit E1 and inhibited PDH enzyme complex activities (Soo et al. 2007). A similar mode of action could be assumed for MDCKSUS2 cells with pirin decrease in maximum enzyme activity despite the increase in the protein expression level of PDH (Table 2).
Second, the cell-cell adhesion protein cadherin-1 (also known as E-cadherin) was distinctly less expressed in MDCKSUS2 cells (Online Resource 3), certainly, related to loss of adhesive connections after adaptation to suspension growth. Moreover, a study with tumor cells of breast cancer showed a direct correlation of decreased E-cadherin expression and decreased glycolytic capacity mediated by the loss of hypoxia response genes (Chu et al. 2013).
Third, several studies support that CAV1 is involved in the modulation of glycolytic activities as well as bioenergetics of mitochondria, as summarized by Nwosu et al. (2016). However, the mechanisms for the CAV1-mediated regulation of glycolysis and mitochondrial function are largely unclear. A detailed study on colorectal cancer cells described the enhancement of aerobic glycolysis by increased CAV1 expression (Ha et al. 2012). In this study, MDCKSUS2 cells showed a down-regulation of glycolytic protein expression (Table 2), which could be related to the reduced expression levels of CAV1. The modulation mechanism of glycolysis activity by CAV1 was described to be related to AMPK activation followed by a p53-dependent G1 cell cycle arrest and autophagy (Ha et al. 2012). Assuming a similar mechanism for MDCK cells, AMPK was evaluated and found to be increased 4-fold for MDCKSUS2 cells compared to MDCKADH cells (Table 3). AMPK is further described to be an important metabolic checkpoint which regulates cell cycle arrest by p53 in mammalian cells (Jones et al. 2005) and its role should be further investigated in more detailed metabolic studies for MDCK cells.
Fourth, regarding the obvious shift in glycolytic enzyme activity, a total of eight respiratory chain proteins were detected to be on average 1.6-fold increased for MDCKSUS2 cells compared to MDCKADH cells (Table 4). An increased protein expression of respiratory chain enzymes is adding a further option for a shift in intracellular metabolism. This cellular adaptation could balance the demand of cellular energy. Among many other possibilities, these proteomic findings might also be related to the reduced expression of CAV1 as already mentioned. Inhibition of mitochondrial activities by CAV1 was described to be related to mediate a suppressor activity in H-Ras–driven transformation (Rimessi et al. 2014). Correspondingly, when evaluating Ras-related proteins in our experimental set-up, it could be seen that four Ras-related proteins had a decreased expression level in MDCKSUS2 cells (Table 4).
With the chosen approach in this study, interconnections and correlations on different cellular levels were tracked and key players were identified regarding the adaptation of MDCK cells to growth in suspension. Clearly, by combining the findings of complex analytics and mathematical model evaluation allowed for deeper insights into the cellular response after cell line adaptation. Based on our approach, next steps in verifying the role of possible key players in animal cell metabolism should apply multi-disciplinary approaches that combine in-depth metabolite and enzyme analytics and proteomics together with mathematical modeling to capture the full network of interactions within a cell and its adaptations to new conditions.
Data availability
All relevant data and material is given in the manuscript.
References
Bandaranayake AD, Almo SC (2014) Recent advances in mammalian protein production. FEBS Lett 588(2):253–260. https://doi.org/10.1016/j.febslet.2013.11.035
Barsnes H, Vaudel M, Colaert N, Helsens K, Sickmann A, Berven FS, Martens L (2011) Compomics-utilities: an open-source Java library for computational proteomics. BMC bioinformatics 12:70. https://doi.org/10.1186/1471-2105-12-70
Bock A, Sann H, Schulze-Horsel J, Genzel Y, Reichl U, Mohler L (2009) Growth behavior of number distributed adherent MDCK cells for optimization in microcarrier cultures. Biotechnol Prog 25(6):1717–1731. https://doi.org/10.1002/Btpr.262
Burkhart JM, Schumbrutzki C, Wortelkamp S, Sickmann A, Zahedi RP (2012) Systematic and quantitative comparison of digest efficiency and specificity reveals the impact of trypsin quality on MS-based proteomics. J Proteome 75(4):1454–1462. https://doi.org/10.1016/j.jprot.2011.11.016
Chu C, Lugovtsev V, Golding H, Betenbaugh M, Shiloach J (2009) Conversion of MDCK cell line to suspension culture by transfecting with human siat7e gene and its application for influenza virus production. Proc Natl Acad Sci USA 106(35):14802–14807. https://doi.org/10.1073/pnas.0905912106
Chu K, Boley KM, Moraes R, Barsky SH, Robertson FM (2013) The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism. Oncotarget 4(3):446–462. https://doi.org/10.18632/oncotarget.872
Consortium U (2014) Activities at the Universal Protein Resource (UniProt). Nucleic Acids Res 42(11):7486
Cruz HJ, Ferreira AS, Freitas CM, Moreira JL, Carrondo MJ (1999) Metabolic responses to different glucose and glutamine levels in baby hamster kidney cell culture. Appl Microbiol Biotechnol 51(5):579–585
Donis RO, Influenza Cell Culture Working G, Davis CT, Foust A, Hossain MJ, Johnson A, Klimov A, Loughlin R, Xu X, Tsai T, Blayer S, Trusheim H, Colegate T, Fox J, Taylor B, Hussain A, Barr I, Baas C, Louwerens J, Geuns E, Lee MS, Venhuizen O, Neumeier E, Ziegler T (2014) Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing. Vaccine 32(48):6583–6590. https://doi.org/10.1016/j.vaccine.2014.06.045
Doolan P, Meleady P, Barron N, Henry M, Gallagher R, Gammell P, Melville M, Sinacore M, McCarthy K, Leonard M, Charlebois T, Clynes M (2010) Microarray and proteomics expression profiling identifies several candidates, including the valosin-containing protein (VCP), involved in regulating high cellular growth rate in production CHO cell lines. Biotechnol Bioeng 106(1):42–56. https://doi.org/10.1002/bit.22670
Doroshenko A, Halperin SA (2009) Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines). Expert Rev Vaccines 8(6):679–688. https://doi.org/10.1586/erv.09.31
Egea JA, Rodriguez-Fernandez M, Banga JR, Martí R (2007) Scatter Search for chemical and bioprocess optimization. J Glob Optim 37(3):481–503
Genzel Y, Behrendt I, Konig S, Sann H, Reichl U (2004) Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. Vaccine 22(17-18):2202–2208. https://doi.org/10.1016/j.vaccine.2003.11.041
Genzel Y, Fischer M, Reichl U (2006) Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Vaccine 24(16):3261–3272. https://doi.org/10.1016/j.vaccine.2006.01.019
Genzel Y, Reichl U (2009) Continuous cell lines as a production system for influenza vaccines. Expert Rev Vaccines 8(12):1681–1692. https://doi.org/10.1586/erv.09.128
Genzel Y, Ritter JB, Konig S, Alt R, Reichl U (2005) Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells. Biotechnol Prog 21(1):58–69. https://doi.org/10.1021/bp049827d
Gregersen JP, Schmitt HJ, Trusheim H, Broker M (2011) Safety of MDCK cell culture-based influenza vaccines. Future Microbiol 6(2):143–152. https://doi.org/10.2217/fmb.10.161
Ha TK, Her NG, Lee MG, Ryu BK, Lee JH, Han J, Jeong SI, Kang MJ, Kim NH, Kim HJ, Chi SG (2012) Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription. Cancer Res 72(16):4097–4109. https://doi.org/10.1158/0008-5472.CAN-12-0448
Huang D, Peng WJ, Ye Q, Liu XP, Zhao L, Fan L, Xia-Hou K, Jia HJ, Luo J, Zhou LT, Li BB, Wang SL, Xu WT, Chen Z, Tan WS (2015) Serum-free suspension culture of MDCK cells for production of influenza H1N1 vaccines. PLoS ONE 10(11):e0141686. https://doi.org/10.1371/journal.pone.0141686
Janke R, Genzel Y, Freund S, Wolff MW, Grammel H, Ruhmkorf C, Seidemann J, Wahl A, Reichl U (2010a) Expression, purification, and characterization of a His6-tagged glycerokinase from Pichia farinosa for enzymatic cycling assays in mammalian cells. J Biotechnol 150(3):396–403. https://doi.org/10.1016/j.jbiotec.2010.09.963
Janke R, Genzel Y, Handel N, Wahl A, Reichl U (2011) Metabolic adaptation of MDCK cells to different growth conditions: effects on catalytic activities of central metabolic enzymes. Biotechnol Bioeng 108(11):2691–2704. https://doi.org/10.1002/bit.23215
Janke R, Genzel Y, Wahl A, Reichl U (2010b) Measurement of key metabolic enzyme activities in mammalian cells using rapid and sensitive microplate-based assays. Biotechnol Bioeng 107(3):566–581. https://doi.org/10.1002/bit.22817
Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18(3):283–293. https://doi.org/10.1016/j.molcel.2005.03.027
Kildegaard HF, Baycin-Hizal D, Lewis NE, Betenbaugh MJ (2013) The emerging CHO systems biology era: harnessing the ‘omics revolution for biotechnology. Curr Opin Biotechnol 24(6):1102–1107. https://doi.org/10.1016/j.copbio.2013.02.007
Kluge S, Benndorf D, Genzel Y, Scharfenberg K, Rapp E, Reichl U (2015) Monitoring changes in proteome during stepwise adaptation of a MDCK cell line from adherence to growth in suspension. Vaccine 33:4269–4280. https://doi.org/10.1016/j.vaccine.2015.02.077
Kumar N, Gammell P, Meleady P, Henry M, Clynes M (2008) Differential protein expression following low temperature culture of suspension CHO-K1 cells. BMC Biotechnol 8:42. https://doi.org/10.1186/1472-6750-8-42
Lohr V, Genzel Y, Behrendt I, Scharfenberg K, Reichl U (2010) A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor. Vaccine 28(38):6256–6264
Luz-Hernández KR, Rojas-del Calvo L, Rabasa-Legón Y, Lage-Castellanos A, Castillo Vitlloch A, Díaz J, Gaskell S (2008) Metabolic and proteomic study of NSO myeloma cell line following the adaptation to protein-free medium. J Proteome 71(2):133–147
Manini I, Domnich A, Amicizia D, Rossi S, Pozzi T, Gasparini R, Panatto D, Montomoli E (2015) Flucelvax (Optaflu) for seasonal influenza. Expert Rev Vaccines 14(6):789–804. https://doi.org/10.1586/14760584.2015.1039520
Manza LL, Stamer SL, Ham AJ, Codreanu SG, Liebler DC (2005) Sample preparation and digestion for proteomic analyses using spin filters. Proteomics 5(7):1742–1745. https://doi.org/10.1002/pmic.200401063
Meleady P, Doolan P, Henry M, Barron N, Keenan J, O'Sullivan F, Clarke C, Gammell P, Melville MW, Leonard M, Clynes M (2011) Sustained productivity in recombinant Chinese hamster ovary (CHO) cell lines: proteome analysis of the molecular basis for a process-related phenotype. BMC Biotechnol 11:78. https://doi.org/10.1186/1472-6750-11-78
Mohler L, Bock A, Reichl U (2008) Segregated mathematical model for growth of anchorage-dependent MDCK cells in microcarrier culture. Biotechnol Prog 24(1):110–119. https://doi.org/10.1021/bp0701923
Mudunuri U, Che A, Yi M, Stephens RM (2009) bioDBnet: the biological database network. Bioinformatics 25(4):555–556. https://doi.org/10.1093/bioinformatics/btn654
Nwosu ZC, Ebert MP, Dooley S, Meyer C (2016) Caveolin-1 in the regulation of cell metabolism: a cancer perspective. Mol Cancer 15(1):71. https://doi.org/10.1186/s12943-016-0558-7
Onions D, Egan W, Jarrett R, Novicki D, Gregersen JP (2010) Validation of the safety of MDCK cells as a substrate for the production of a cell-derived influenza vaccine. Biologicals 38(5):544–551. https://doi.org/10.1016/j.biologicals.2010.04.003
Pascoe DE, Arnott D, Papoutsakis ET, Miller WM, Andersen DC (2007) Proteome analysis of antibody-producing CHO cell lines with different metabolic profiles. Biotechnol Bioeng 98(2):391–410. https://doi.org/10.1002/bit.21460
Perdue ML, Arnold F, Li S, Donabedian A, Cioce V, Warf T, Huebner R (2011) The future of cell culture-based influenza vaccine production. Expert Rev Vaccines 10(8):1183–1194. https://doi.org/10.1586/erv.11.82
Peschel B, Frentzel S, Laske T, Genzel Y, Reichl U (2013) Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line. Vaccine 31(48):5693–5699. https://doi.org/10.1016/j.vaccine.2013.09.051
R Core Team (2014) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org
Rehberg M, Rath A, Ritter JB, Genzel Y, Reichl U (2014a) Changes in intracellular metabolite pools during growth of adherent MDCK cells in two different media. Appl Microbiol Biotechnol 98(1):385–397. https://doi.org/10.1007/s00253-013-5329-4
Rehberg M, Ritter JB, Genzel Y, Flockerzi D, Reichl U (2013a) The relation between growth phases, cell volume changes and metabolism of adherent cells during cultivation. J Biotechnol 164(4):489–499. https://doi.org/10.1016/j.jbiotec.2013.01.018
Rehberg M, Ritter JB, Reichl U (2014b) Glycolysis is governed by growth regime and simple enzyme regulation in adherent MDCK cells. PLoS Comput Biol 10(10):e1003885. https://doi.org/10.1371/journal.pcbi.1003885
Rehberg M, Wetzel M, Ritter JB, Reichl U (2013b) The regulation of glutaminolysis and citric acid cycle activity during mammalian cell cultivation. IFAC Proc Vol 46(31):48–53. https://doi.org/10.3182/20131216-3-IN-204400011
Rimessi A, Marchi S, Patergnani S, Pinton P (2014) H-Ras-driven tumoral maintenance is sustained through caveolin-1-dependent alterations in calcium signaling. Oncogene 33(18):2329–2340. https://doi.org/10.1038/onc.2013.192
Ryll T, Valley U, Wagner R (1994) Biochemistry of growth inhibition by ammonium ions in mammalian cells. Biotechnol Bioeng 44(2):184–193. https://doi.org/10.1002/bit.260440207
Shukla P, Vogl C, Wallner B, Rigler D, Muller M, Macho-Maschler S (2015) High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells. BMC Genomics 16:944. https://doi.org/10.1186/s12864-015-2036-9
Soo PC, Horng YT, Lai MJ, Wei JR, Hsieh SC, Chang YL, Tsai YH, Lai HC (2007) Pirin regulates pyruvate catabolism by interacting with the pyruvate dehydrogenase E1 subunit and modulating pyruvate dehydrogenase activity. J Bacteriol 189(1):109–118. https://doi.org/10.1128/JB.00710-06
Sussman I, Erecinska M, Wilson DF (1980) Regulation of cellular energy metabolism: the Crabtree effect. Biochim Biophys Acta 591(2):209–223
van Wielink R, Kant-Eenbergen HC, Harmsen MM, Martens DE, Wijffels RH, Coco-Martin JM (2011) Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines. J Virol Methods 171(1):53–60. https://doi.org/10.1016/j.jviromet.2010.09.029
Vaudel M, Barsnes H, Berven FS, Sickmann A, Martens L (2011) SearchGUI: an open-source graphical user interface for simultaneous OMSSA and X!Tandem searches. Proteomics 11(5):996–999. https://doi.org/10.1002/pmic.201000595
Acknowledgments
This work was supported by the Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen, the Regierende Bürgermeister von Berlin–Senatskanzlei–Wissenschaft und Forschung, and the Bundesministerium für Bildung und Forschung (via funding to A. S./Leibniz-Institut für Analytische Wissenschaften–ISAS–e.V.). We thank Nadine Händel for the technical assistance in enzyme assays, Marcus Hoffmann for the establishment of a monolithic HPLC system for protein digestion control and Yvonne Pasing for the support in mass spectrometric analysis.
Code availability
Not applicable.
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Contributions
SP, MR, JR, DB, YG, TM, AS, ER, and UR conceived and designed research. SP, MR, and JR conducted experiments. SP, MR, JR, and TM analyzed data. SP, MR, and YG wrote the manuscript. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Sabine Pech and Markus Rehberg are shared first authorship
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pech, S., Rehberg, M., Janke, R. et al. Tracking changes in adaptation to suspension growth for MDCK cells: cell growth correlates with levels of metabolites, enzymes and proteins. Appl Microbiol Biotechnol 105, 1861–1874 (2021). https://doi.org/10.1007/s00253-021-11150-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-021-11150-z